While people collapse with cardiac arrest during exercise, they typically “crumple” with exercise-induced fainting. Ben Levine, M.D., discusses how to tell the difference and what to do for each.
Drugs like Ozempic, Wegovy, and Mounjaro are making headlines for their weight-loss prowess, but these GLP-1 RAs also reduce the risk of heart attack, stroke, and cardiovascular events in patients with Type 2 diabetes.
New AHA guidelines highlight the benefits of SGLT2i medications for patients with heart failure and advances in diagnosing and treating ATTR amyloidosis.
South Asian patients tend to develop heart disease earlier in life and at lower BMIs. Explore a new program at UT Southwestern designed to identify patients at risk and intervene to save lives.
South Asian Americans are at increased risk of heart disease. This Diwali, try these recipes that benefit heart health without sacrificing sweet, savory flavor.
Caffeine is a daily habit for many U.S. kids and teens. Pediatric cardiologist Colin Kane, M.D., discusses how caffeine affects kids’ health, plus tasty beverage swaps.
Rina Mauricio, M.D., explains how UT Southwestern's expert cardio-obstetrics team collaborates to provide the best care for pregnant patients with heart conditions.
Eating well doesn’t have to break the bank. Consider these five building blocks to start your nourishing pantry from UT Southwestern Culinary Medicine Director Jaclyn Albin, M.D., and registered dietician Milette Siler.
A surprise finding in SGLT2 inhibitor drug research has revealed a potentially groundbreaking heart failure treatment. Learn more from Darren McGuire, M.D.
New research led by UT Southwestern's Parag Joshi, M.D., shows a direct tie between high heart attack risk and dual diagnoses of coronary artery disease and high LP(a) cholesterol.